Simon Rule
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research 96
- Pathology and Forensic Medicine top 0.2%
- Lymphoma Diagnosis and Treatment 112
- Oncology top 1%
- Viral-associated cancers and disorders 40
- CAR-T cell therapy research 15
- Hematology top 2%
- Chronic Myeloid Leukemia Treatments 16
- Immunology top 5%
-
- Acute Lymphoblastic Leukemia research 13
-
- CNS Lymphoma Diagnosis and Treatment 10
-
- Monoclonal and Polyclonal Antibodies Research 9
Simon Rule
150 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Genetics 1.6k
- Pathology and Forensic Medicine 2.4k
- Oncology 1.7k
- Hematology 593
- Immunology 519
Countries citing papers authored by Simon Rule
This map shows the geographic impact of Simon Rule's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Rule with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Rule more than expected).
Fields of papers citing papers by Simon Rule
This network shows the impact of papers produced by Simon Rule. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Rule. The network helps show where Simon Rule may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Simon Rule, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 1 | |
| 3 | 2021 | 63 | |
| 4 | 2020 | 75 | |
| 5 | 2020 | 47 | |
| 6 | 2020 | 13 | |
| 7 | 2020 | 6 | |
| 8 | 2020 | 132 | |
| 9 | 2019 | 16 | |
| 10 | 2019 | 4 | |
| 11 | 2018 | 1 | |
| 12 | 2017 | 4 | |
| 13 | 2017 | 9 | |
| 14 | 2017 | 3 | |
| 15 | 2017 | 15 | |
| 16 | 2015 | 9 | |
| 17 | IMPACT OF PRIOR TREATMENT ON PFS FOR RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA PATIENTS RANDOMIZED TO LENALIDOMIDE VS INVESTIGATOR'S CHOICE: A SUBGROUP ANALYSIS OF THE PHASE II MCL-002 (SPRINT) STUDY | 2015 | 2 |
| 18 | 2012 | 7 | |
| 19 | 2009 | 20 | |
| 20 | 1994 | 24 |
About Simon Rule
Simon Rule is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology, having authored 155 papers that have together received 3.4k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (112 papers), Chronic Lymphocytic Leukemia Research (96 papers), Viral-associated cancers and disorders (40 papers), Chronic Myeloid Leukemia Treatments (16 papers), CAR-T cell therapy research (15 papers), Acute Lymphoblastic Leukemia research (13 papers), CNS Lymphoma Diagnosis and Treatment (10 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). The work is most often cited by research in Genetics (1.6k citations), Pathology and Forensic Medicine (2.4k citations) and Oncology (1.7k citations). Simon Rule has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include M. Dreyling, Marco Ladetto, Steven Le Gouill, Mats Jerkeman, Jan Walewski, Ofer Shpilberg, Olivier Hermine, Elı́as Campo, Michele Ghielmini and Gilles Salles. Their work appears in journals such as Blood, British Journal of Haematology, Journal of Clinical Oncology, Hematological Oncology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.